Updated trends in US brand-name and generic drug competition-Reference-Cited by-同舟云学术

Updated trends in US brand-name and generic drug competition

Published:2016-04-20 Issue:9 Volume:19 Page:836-844
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Grabowski Henry¹,Long Genia²,Mortimer Richard²,Boyo Ani²

Affiliation:

1. Duke University, Durham, NC, USA;

2. Analysis Group, Inc., Boston, MA, USA

Funder

Pharmaceutical Research and Manufacturers of America Foundation

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2016.1176578

Reference11 articles.

1. Pharmaceuticals in U.S. Health Care: Determinants of Quantity and Price

2. Office of the Assistant Secretary for Planning and Evaluation (ASPE Issue Brief). Expanding the use of generic drugs. Washington, DC: ASPE, 2010. www.aspe.hhs.gov/sp/reports/2010/genericdrugs/ib.pdf. Accessed 2, October 2013

3. Medicines use and spending shifts: a review of the use of medicines in the U.S. in 2014. IMS Institute for Healthcare Informatics. www.theimsinstitute.org/en/thought-leadership/ims-institute/reports/medicines-use-in-the-us-2014#ims-form. Accessed 14, December 2015

4. The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patent Laws and the Public Health Puzzle: Comparing India’s Well-Thought-Out Patent Opposition Model with the U.S. and EU Model;SSRN Electronic Journal;2023

2. Peltzman Revisited: Quantifying 21st-Century Opportunity Costs of Food and Drug Administration Regulation;The Journal of Law and Economics;2022-11-02

3. Estimating the impact of biosimilar entry on prices and expenditures in rheumatoid arthritis: a case study of targeted immune modulators;Journal of Medical Economics;2022-09-28

4. Who initiates price competition when generic entrants are introduced into the South Korean pharmaceutical market?;Frontiers in Public Health;2022-09-14

5. Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population;Journal of General Internal Medicine;2022-06-01